Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) EPS (Weighted Average and Diluted) (2016 - 2020)

Historic EPS (Weighted Average and Diluted) for Conmed (CNMD) over the last 11 years, with Q4 2020 value amounting to $0.81.

  • Conmed's EPS (Weighted Average and Diluted) rose 6530.61% to $0.81 in Q4 2020 from the same period last year, while for Dec 2020 it was $0.28, marking a year-over-year decrease of 7052.63%. This contributed to the annual value of $1.51 for FY2025, which is 6447.06% down from last year.
  • As of Q4 2020, Conmed's EPS (Weighted Average and Diluted) stood at $0.81, which was up 6530.61% from $0.23 recorded in Q3 2020.
  • Conmed's EPS (Weighted Average and Diluted)'s 5-year high stood at $1.65 during Q4 2017, with a 5-year trough of -$0.96 in Q2 2020.
  • Over the past 5 years, Conmed's median EPS (Weighted Average and Diluted) value was $0.23 (recorded in 2019), while the average stood at $0.26.
  • As far as peak fluctuations go, Conmed's EPS (Weighted Average and Diluted) soared by 58750.0% in 2017, and later plummeted by 60526.32% in 2020.
  • Quarter analysis of 5 years shows Conmed's EPS (Weighted Average and Diluted) stood at $0.24 in 2016, then soared by 587.5% to $1.65 in 2017, then plummeted by 67.27% to $0.54 in 2018, then decreased by 9.26% to $0.49 in 2019, then surged by 65.31% to $0.81 in 2020.
  • Its EPS (Weighted Average and Diluted) was $0.81 in Q4 2020, compared to $0.23 in Q3 2020 and -$0.96 in Q2 2020.